123 related articles for article (PubMed ID: 35223528)
41. Exosomes are involved in the intercellular transfer of rapamycin resistance in the breast cancer cells.
Shchegolev YY; Sorokin DV; Scherbakov AM; Andreeva OE; Salnikova DI; Mikhaevich EI; Gudkova MV; Krasil'nikov MA
Bioimpacts; 2023; 13(4):313-321. PubMed ID: 37645026
[TBL] [Abstract][Full Text] [Related]
42. Promising molecular mechanisms responsible for gemcitabine resistance in cancer.
Jia Y; Xie J
Genes Dis; 2015 Dec; 2(4):299-306. PubMed ID: 30258872
[TBL] [Abstract][Full Text] [Related]
43. Cancer Stem Cell-Exosomes, Unexposed Player in Tumorigenicity.
Al-Sowayan BS; Al-Shareeda AT; Alrfaei BM
Front Pharmacol; 2020; 11():384. PubMed ID: 32317966
[No Abstract] [Full Text] [Related]
44. Tumorigenic and tumoricidal properties of exosomes in cancers; a forward look.
Abbasi-Malati Z; Azizi SG; Milani SZ; Serej ZA; Mardi N; Amiri Z; Sanaat Z; Rahbarghazi R
Cell Commun Signal; 2024 Feb; 22(1):130. PubMed ID: 38360641
[TBL] [Abstract][Full Text] [Related]
45. Exosomes: Emerging Modulators of Pancreatic Cancer Drug Resistance.
Di Donato M; Medici N; Migliaccio A; Castoria G; Giovannelli P
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835408
[TBL] [Abstract][Full Text] [Related]
46. Characterization and verification of MMP family members as potential biomarkers in kidney clear cell renal carcinoma.
Zhao T; Li X; Li M; Jamil M; Zhang J
Am J Cancer Res; 2023; 13(9):3941-3962. PubMed ID: 37818055
[TBL] [Abstract][Full Text] [Related]
47. A New Potential Therapeutic Target for Cancer in Ubiquitin-Like Proteins-UBL3.
Zhang H; Chen B; Waliullah ASM; Aramaki S; Ping Y; Takanashi Y; Zhang C; Zhai Q; Yan J; Oyama S; Kahyo T; Setou M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674743
[TBL] [Abstract][Full Text] [Related]
48. Deciphering the action mechanism of paeoniflorin in suppressing pancreatic cancer: A network pharmacology study and experimental validation.
Cao C; Zhao W; Chen X; Shen B; Wang T; Wu C; Rong X
Front Pharmacol; 2022; 13():1032282. PubMed ID: 36339551
[No Abstract] [Full Text] [Related]
49. Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinoma.
Xu L; Yan M; Long J; Liu M; Yang H; Li W
Front Oncol; 2022; 12():967982. PubMed ID: 36158683
[TBL] [Abstract][Full Text] [Related]
50. Roles of exosomes as drug delivery systems in cancer immunotherapy: a mini-review.
Fang Z; Ding Y; Xue Z; Li P; Li J; Li F
Discov Oncol; 2022 Aug; 13(1):74. PubMed ID: 35962862
[TBL] [Abstract][Full Text] [Related]
51. Extracellular Vesicles Inhibit the Response of Pancreatic Ductal Adenocarcinoma Cells to Gemcitabine and TRAIL Treatment.
Rimmer E; Rashid S; Kraev I; Miralles F; Elia A
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887158
[TBL] [Abstract][Full Text] [Related]
52. Exosomes and their roles in the chemoresistance of pancreatic cancer.
Pan Y; Tang H; Li Q; Chen G; Li D
Cancer Med; 2022 Dec; 11(24):4979-4988. PubMed ID: 35587712
[TBL] [Abstract][Full Text] [Related]
53. Cancer-Associated Fibroblasts Confer Gemcitabine Resistance to Pancreatic Cancer Cells through PTEN-Targeting miRNAs in Exosomes.
Richards KE; Xiao W; Hill R; On Behalf Of The Usc Pancreas Research Team
Cancers (Basel); 2022 Jun; 14(11):. PubMed ID: 35681792
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy.
Xiong J; Wang D; Wei A; Ke N; Wang Y; Tang J; He S; Hu W; Liu X
Oncotarget; 2017 Dec; 8(64):107500-107512. PubMed ID: 29296182
[TBL] [Abstract][Full Text] [Related]
55. GATA1 Promotes Gemcitabine Resistance in Pancreatic Cancer through Antiapoptotic Pathway.
Chang Z; Zhang Y; Liu J; Guan C; Gu X; Yang Z; Ye Q; Ding L; Liu R
J Oncol; 2019; 2019():9474273. PubMed ID: 31093285
[TBL] [Abstract][Full Text] [Related]
56. The Role of Exosomes in Pancreatic Cancer From Bench to Clinical Application: An Updated Review.
Chen K; Wang Q; Kornmann M; Tian X; Yang Y
Front Oncol; 2021; 11():644358. PubMed ID: 33718244
[TBL] [Abstract][Full Text] [Related]
57. Chemoresistance Transmission
Li X; Li K; Li M; Lin X; Mei Y; Huang X; Yang H
Front Oncol; 2022; 12():844648. PubMed ID: 35223528
[TBL] [Abstract][Full Text] [Related]
58. Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer.
Comandatore A; Immordino B; Balsano R; Capula M; Garajovà I; Ciccolini J; Giovannetti E; Morelli L
Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204377
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
